ACTRN12622000215729尚未招募未知
A randomized, double-blind, non-inferiority trial evaluating the efficacy and safety of two different mouthrinses on patients with gingival inflammation.
Polytechnic University of Marche0 个研究点目标入组 82 人开始时间: 2022年2月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 82
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 75 Years（—）
- 性别
- All
入选标准
- •minimum of 20 teeth, good physical health, gingivitis, periodontitis stages I or II
排除标准
- •1) active caries
- •2) wearers of dentures and of orthodontic appliances;
- •3) severe malocclusion;
- •4) use of oral antiseptics in the previous three months;
- •5) subjects with medical disorders;
- •6) undergoing antibiotic or other antimicrobial therapy in the previous 3 months;
- •7) the presence of any systemic disease that could alter the production or composition of the saliva or dental plaque;
- •8) individuals with an allergy to any ingredients used in the study;
- •9) pregnant women.
研究者
相似试验
尚未招募
4 期
Comparative trial of two gels in mild to moderate acneCTRI/2019/08/020563KPC Medical College and Hospital
进行中（未招募）
1 期
Occurrence of hypophosphataemia in patients with iron deficiency anemia caused by inflammatory bowel disease after treatment with iron isomaltoside or iron carboxymaltoseEUCTR2017-002452-87-DKPharmacosmos A/S120
进行中（未招募）
1 期
A study comparing the incidence of low phosphate levels in the blood (hypophosphatemia) after treatment with iron isomaltoside (Monofer®) and ferric carboxymaltose (Ferinject®) in patients with iron deficiency anaemia (low red blood cell count due to low iron levels in the blood) caused by swelling in the gut (known as inflammatory bowel disease).Iron deficiency anaemia due to inflammatory bowel diseaseMedDRA version: 20.0Level: LLTClassification code 10002062Term: Anaemia iron deficiencySystem Organ Class: 100000004851EUCTR2017-002452-87-GBPharmacosmos A/S120
进行中（未招募）
1 期
Occurrence of hypophosphataemia in patients with iron deficiency anemia caused by inflammatory bowel disease after treatment with ironisomaltoside or iron carboxymaltoseEUCTR2017-002452-87-DEPharmacosmos A/S120
进行中（未招募）
1 期
Occurrence of hypophosphataemia in patients with iron deficiency anemia caused by inflammatory bowel disease after treatment with iron isomaltoside or iron carboxymaltoseIron deficiency anemia in subject with inflammatory bowel diseaseMedDRA version: 20.0Level: SOCClassification code 10005329Term: Blood and lymphatic system disordersSystem Organ Class: 10005329 - Blood and lymphatic system disordersMedDRA version: 20.0Level: LLTClassification code 10079322Term: Anaemia of chronic inflammationSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2017-002452-87-SEPharmacosmos A/S120